Research on heart patients throws doubt on the efficacy of low blood pressure
This article was originally published in Clinica
Executive Summary
Lowered blood pressure during an exercise stress test in recovering heart-attack patients may not be the positive indicator of long-term health as previously thought, but could actually point to an increased risk of premature death.
You may also be interested in...
Health And Wellness Trademark Review 3 December, 2019
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Deal Watch: AstraZeneca Continues Divestments By Offloading US/Canada Seroquel Rights
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: